Consolidated Statements of Cash Flows (USD $)
12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Operating activities    
Net loss $ (26,868,198) $ (16,590,827)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation 23,249 47,747
Share-based compensation expense 391,393 295,106
Changes in operating assets and liabilities:    
Accounts receivable (35,889) 48,634
Prepaid expenses and other assets (574,341) (34,189)
Accounts payable 3,353,459 (554,256)
Accrued liabilities and employee benefits 2,785,736 (448,493)
Deferred revenue (1,666,674) (1,666,659)
Net cash used in operating activities (22,591,265) (18,902,937)
Investing activities    
Purchases of investments   (12,000,000)
Maturities of investments 1,500,000 17,700,122
Purchase of property and equipment (33,255) (38,957)
Net cash provided by investing activities 1,466,745 5,661,165
Financing activities    
Proceeds from issuance of convertible promissory notes, net 100,000 15,163,004
Proceeds from stock option exercises 332,938 31,081
Proceeds from stock subscription 109,834  
Gross proceeds of private placement 43,841,850  
Payment of costs of private placement (3,754,706)  
Net cash provided by financing activities 40,629,916 15,194,085
Net increase in cash and cash equivalents 19,505,396 1,952,313
Cash and cash equivalents at beginning of year 15,645,528 13,693,215
Cash and cash equivalents at end of year 35,150,924 15,645,528
Cash paid for interest 11,320  
Cash paid for taxes $ 31,437 $ 13,857